-
NUMBER OF INSIDER BUYING
(Last 12 Months)
2 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
2 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$18.48 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$18,819
Verve Therapeutics, Inc. Insider Transactions
Verve Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Ashe Andrew D.
See Remarks |
Buy | 76,000 @ $6.26 | $475,760 | 342,509 | 05/14/2024 | 05/15/2024 | |
|
Nickerson Joan
Chief Administrative Officer |
Sell | 1,514 @ $8.24 | $12,475 | 8,659 | 04/02/2024 | 04/03/2024 | |
|
Yeshwant Krishna
Director, 10 percent owner: |
Buy | 1,800,000 @ $10.00 | $18.00 M | 1,800,000 | 12/01/2023 | 12/05/2023 | |
|
Dorval Allison
CFO |
Sell | 554 @ $11.45 | $6,343 | 4,060 | 11/29/2023 | 12/01/2023 | |
|
Bellinger Andrew
CSO & CMO |
Sell | 865 @ $22.95 | $19,852 | 6,629 | 12/01/2022 | 12/02/2022 | |
|
Dorval Allison
CFO |
Sell | 554 @ $22.10 | $12,243 | 2,186 | 11/29/2022 | 12/01/2022 |
Verve Therapeutics, Inc. Frequently Asked Questions
-
Who is on Verve Therapeutics, Inc.'s Insider Roster?
The list of insiders at Verve Therapeutics, Inc. includes Dorval Allison, Yeshwant Krishna, Nickerson Joan, Ashe Andrew D..
-
How much insider selling is happening at Verve Therapeutics, Inc.?
Insiders have sold a total of 2,068 Verve Therapeutics, Inc. shares in the last 12 months for a total of 18,819 sold.
-
Which Verve Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Verve Therapeutics, Inc. shares in the last 12 months: Dorval Allison ($6,343), Nickerson Joan ($12,475),
-
How much insider buying is happening at Verve Therapeutics, Inc.?
Insiders have purchased a total of 1.88 M Verve Therapeutics, Inc. shares in the last 12 months for a total of 18.48 M sold.
-
Which Verve Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Verve Therapeutics, Inc. shares in the last 12 months: Yeshwant Krishna ($18.00 M), Ashe Andrew D. ($475,760),